Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Sunday, October 12, 2008, 9:09AM ET - U.S. Markets Closed. Dow Down 1.49% Nasdaq Up 0.27%
Wyeth (WYE)On Oct 10: 29.89  Down 2.07 (6.48%)  
MORE ON WYE
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Wyeth
Five Giralda Farms
Madison, NJ 07940
United States - Map
Phone: 973-660-5000
Fax: 973-660-5771
Web Site: http://www.wyeth.com

DETAILS 
Index Membership:S&P 500
S&P 1500 Super Comp
Sector:Healthcare
Industry:Drug Manufacturers - Major
Full Time Employees:50,527

BUSINESS SUMMARY 
Wyeth engages in the discovery, development, manufacture, distribution, and sale of pharmaceuticals, consumer healthcare, and animal health products. It operates through three segments: Pharmaceuticals, Consumer Healthcare, and Animal Health. The Pharmaceuticals segment offers human ethical pharmaceuticals, biotechnology products, vaccines, and nutrition products. Its principal products include neuroscience therapies, vaccines, musculoskeletal therapies, nutrition products, gastroenterology drugs, anti-infectives, oncology therapies, hemophilia treatments, immunological products, and women’s health care products. The Consumer Healthcare segment provides over-the-counter health care products comprising analgesics, cough/cold/allergy remedies, nutritional supplements, as well as hemorrhoidal, asthma, and personal care items. The Animal Health segment offers animal biological and pharmaceutical products consisting of vaccines, pharmaceuticals, parasite control products, and growth implants. The company sells its products to wholesalers, pharmacies, hospitals, physicians, retailers, and other health care institutions worldwide. Wyeth has collaboration agreements with Progenics Pharmaceuticals, Inc. and Trubion Pharmaceuticals, Inc. The company was founded in 1926 and is headquartered in Madison, New Jersey.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Wyeth


    CORPORATE GOVERNANCE 
    Wyeth's Corporate Governance Quotient (CGQ®) as of 1-Oct-08 is better than 72.7% of S&P 500 companies and 98.6% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Bernard Poussot , 56
    Chairman, Chief Exec. Officer, Pres, Head of Consumer Healthcare, Member of Exec. Committee, Member of Law & Regulatory Review Committee, Member of HR & Benefits Committee, Member of Operations Committee, Member of Retirement Committee, Pres of Wyeth Pharmaceuticals and Head of Fort Dodge Animal Health Divisions
    $ 3.05M $ 3.01M
    Mr. Greg Norden , 50
    Chief Financial Officer and Sr. VP
    $ 1.33M $ 259.00K
    Mr. Joseph M. Mahady , 54
    Sr. VP, Member of Operations Committee and Pres of Wyeth Pharmaceuticals
    $ 1.89M $ 2.12M
    Mr. Douglas A. Rogers , 48
    Member of HR & Benefits Committee, Member of Law & Regulatory Review Committee, Member of Operations Committee and Pres of US & New Global Bus. - Wyeth Consumer Healthcare
    N/A N/A
    Mr. Charles A. Portwood , 58
    Member of Law & Regulatory Review Committee and Pres of Technical Operations & Product Supply - Wyeth Pharmaceuticals
    N/A N/A
    Dollar amounts are as of 31-Dec-07 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis